Publications by authors named "Monica Rodolfo"

Claim this Profile
C
Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.
Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, Sara Rigoletto, Gabrina Tragni, Monica Rodolfo

Oncotarget· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Matteo Pallocca, Ivan Molineris, Enrico Berrino, Benedetta Marcozzi, Martina Betti, Monica Rodolfo

J Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-dependent interaction of PTGS2 with miR-146a as risk factor for melanoma and the impact of sex hormones in gene expression in skin cells.
Elisa Orlandi, Laura Ceccuzzi, Francesca Belpinati, Monica Rodolfo, Giovanni Malerba

Melanoma Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case.
Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Monica Rodolfo

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Matteo Pallocca, Ivan Molineris, Enrico Berrino, Benedetta Marcozzi, Martina Betti, Monica Rodolfo

J Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in Plasma Lipid Profiles Associated with Melanoma and Therapy Resistance.
Michele Dei Cas, Chiara Maura Ciniselli, Elisabetta Vergani, Emilio Ciusani, Mariachiara Aloisi, Monica Rodolfo

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells.
Carlotta Guzzetti, Cristina Corno, Elisabetta Vergani, Luca Mirra, Emilio Ciusani, Monica Rodolfo

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D tumor explant as a novel platform to investigate therapeutic pathways and predictive biomarkers in cancer patients.
Monica Rodolfo, Veronica Huber, Mara Cossa, Gianfrancesco Gallino, Biagio E Leone

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles in anti-tumor immunity.
Elisabetta Vergani, Elena Daveri, Viviana Vallacchi, Laura Bergamaschi, Luca Lalli, Monica Rodolfo

Semin Cancer Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.
Elisabetta Vergani, Adele Busico, Matteo Dugo, Andrea Devecchi, Barbara Valeri, Monica Rodolfo

J Invest Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation.
Elisa Orlandi, Elisa De Tomi, Rachele Campagnari, Francesca Belpinati, Monica Rodolfo

Curr Issues Mol Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma.
Elisabetta Vergani, Giovanni L Beretta, Mariachiara Aloisi, Matteo Costantino, Cristina Corno, Monica Rodolfo

Front Cell Dev Biol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
Lorenza Di Guardo, Giovanni Randon, Francesca Corti, Viviana Vallacchi, Alessandra Raimondi, Monica Rodolfo

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
Elisabetta Vergani, Simona Frigerio, Matteo Dugo, Andrea Devecchi, Erika Feltrin, Monica Rodolfo

Genes (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.
Darawan Rinchai, Elena Verzoni, Veronica Huber, Agata Cova, Paola Squarcina, Monica Rodolfo

Clin Transl Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations.
Serena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, Matteo Dugo, Cristina Corno, Monica Rodolfo

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
Elena Daveri, Elisabetta Vergani, Eriomina Shahaj, Laura Bergamaschi, Stefano La Magra, Monica Rodolfo

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
Veronica Huber, Lorenza Di Guardo, Luca Lalli, Daniele Giardiello, Agata Cova, Monica Rodolfo

J Immunother Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk.
Francesca Belpinati, Giovanni Malerba, Melissa Dal Toè, Laura Ceccuzzi, Monica Rodolfo

Exp Dermatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Elisabetta Vergani, Matteo Dugo, Mara Cossa, Simona Frigerio, Lorenza Di Guardo, Monica Rodolfo

Cell Commun Signal· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma.
Ankit Patel, Lucia Fraile Garcia, Viviana Mannella, Luke Gammon, Tiffanie-Marie Borg, Monica Rodolfo

Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Maria Teresa Landi, D Timothy Bishop, Stuart MacGregor, Mitchell J Machiela, Alexander J Stratigos, Monica Rodolfo

Nat Genet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk.
Elisa Orlandi, Chiara Zanot, Albino Poli, Morena Nicolis, Monica Rodolfo

Melanoma Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The density and spatial tissue distribution of CD8 and CD163 immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors.
Daniela Massi, Eliana Rulli, Mara Cossa, Barbara Valeri, Monica Rodolfo

J Immunother Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
Cristina Pellegrini, Francesca Botta, Daniela Massi, Claudia Martorelli, Fabio Facchetti, Monica Rodolfo

Lancet Child Adolesc Health· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis